Yu Li 4
4 · Oncocyte Corp · Filed Oct 14, 2021
Insider Transaction Report
Form 4
Yu Li
VP Cntrllr/Prncpl Acctng Offcr
Transactions
- Award
Option to Purchase Common Stock
2021-06-24+160,000→ 160,000 totalExercise: $4.33Exp: 2031-05-18→ Common Stock (160,000 underlying)
Footnotes (2)
- [F1]This option award was granted on May 18, 2021, but such award was subject to shareholder approval of an increase in the number of shares available for issuance under the Oncocyte 2018 Equity Incentive Plan. Such shareholder approval was received on June 24, 2021.
- [F2]25% of the options will become exercisable after one year of continuous employment from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continued employment on the applicable vesting date.